CL vs PRGO vs EPC Stock Comparison

Colgate Palmolive, Perrigo and Edgewell Personal Care Prices as of Nov 13, 2026 Peers: Industry group
CL Colgate Palmolive Co
$99.67 +7.4% 1M +26.5% 1Y
Market cap
$80.63B
P/E
39.3x
Revenue (TTM)
$21.28B
Div. yield
0.02%
Personal Care Products Consumer Staples
7 wins
PRGO PERRIGO Co plc
$16.26 +1.9% 1M +16.4% 1Y
Market cap
$2.31B
P/E
–
Revenue (TTM)
$4.09B
Div. yield
–
Personal Care Products Consumer Staples
2 wins
EPC EDGEWELL PERSONAL CARE Co
$27.26 -3.3% 1M +48.2% 1Y
Market cap
$1.24B
P/E
–
Revenue (TTM)
—
Div. yield
–
Personal Care Products Consumer Staples
1 win

Head to Head

10 decided of 12

Colgate Palmolive leads on 7 of the 12 questions below (Colgate Palmolive 7, Perrigo 2, Edgewell Personal Care 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCLPRGOEPCLeader
Larger companyMarket capitalisation $80.63B $2.31B $1.24B CL
Cheaper on earningsLower P/E, profitable companies only 39.3x -1.3x -24.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 26.2x 6.7x 13.0x PRGO
Faster revenue growthRevenue growth, trailing twelve months +5.9% -4.5% — CL
More profitableNet margin, trailing twelve months 9.6% -43.3% — CL
Better return on capitalReturn on invested capital 27.6% -27.9% — CL
Less leveragedLower net debt / EBITDA 1.6x -2.2x — PRGO
Higher dividend yieldTrailing dividend yield 0.02% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +26.5% +16.4% +48.2% EPC
Better 5-year returnAnnualised price return, 5 years +5.0%/yr -17.8%/yr -8.8%/yr CL
Less volatileAnnualised volatility, 1 year 23.5% 49.6% 44.0% CL
Higher overall scoreMean of the five percentile scores vs peers 61/100 43/100 48/100 CL

Percentile Scorecard

CLPRGOEPC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCLPRGOEPC
Valuation 54 #26 of 55 57 #24 of 55 63 #21 of 55
Growth 61 #21 of 52 6 #49 of 52 –
Profitability 98 #2 of 50 27 #37 of 50 –
Financial Health 43 #34 of 59 29 #42 of 59 55 #27 of 59
Shareholder Returns 52 #16 of 32 94 #3 of 32 26 #24 of 32
Overall 61 43 48
  • CL ranked among 60 companies in Household and Personal Products
  • PRGO ranked among 60 companies in Household and Personal Products
  • EPC ranked among 60 companies in Household and Personal Products

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCLPRGOEPCSPY
1 month +7.4%+1.9%-3.3% -2.0%
3 months +8.4%+24.7%-4.1% -2.8%
6 months +13.1%+53.3%+71.1% +2.0%
Year to date +26.1%+16.8%+59.9% +10.6%
1 year +26.5%+16.4%+48.2% +12.2%
3 years +30.0%-43.7%-23.5% +68.1%
3 years, per year +9.2%-17.4%-8.6% +18.9%
5 years +27.7%-62.4%-37.0% +61.4%
5 years, per year +5.0%-17.8%-8.8% +10.1%
10 years +47.8%-81.8%-66.5% +248.5%
10 years, per year +4.0%-15.7%-10.4% +13.3%

Risk

MeasureCLPRGOEPCSPY
Volatility, 1Y 23.5%49.6%44.0% 13.6%
Downside volatility, 1Y 21.8%43.6%41.3% 13.9%
Beta vs S&P 500, 1Y -0.101.020.34 1.00
Return / volatility, 1Y 1.130.331.10 0.90
Max drawdown, 5Y -31.1%-78.5%-69.3% -25.4%
From 52-week high 0.0%-4.1%-8.2% -3.2%
52-week high $99.67$16.96$29.69 $779.14
52-week low $76.11$9.25$15.91 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCLPRGOEPC
P/E now vs peer median 38.7xmedian 21.1x -1.3xmedian 21.1x -24.4xmedian 21.1x
P/S now vs peer median 3.7xmedian 2.2x 0.6xmedian 2.2x 0.6xmedian 2.2x
EV/EBITDA now vs peer median 22.5xmedian 14.0x -3.9xmedian 14.0x —median 14.0x
P/FCF now vs peer median 20.9xmedian 17.3x 13.4xmedian 17.3x -125.6xmedian 17.3x
P/B now vs peer median 123.8xmedian 1.9x 0.9xmedian 1.9x 0.9xmedian 1.9x
PEG now vs peer median 3.79median 0.87 0.00median 0.87 —median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCLPRGOEPC
Revenue $21.28B $4.09B –
Gross profit $12.90B $1.32B –
Operating income $3.16B -$1.61B –
Net income $2.17B -$1.77B –
Free cash flow $3.79B $168.20M –
R&D – $92.00M –
EPS (diluted) $2.57 $-12.70 –
Cash & equivalents $1.53B $436.60M $375.60M
Total debt $7.72B $3.29B $1.28B
Shares (diluted) 799.70M 139.40M 46.30M
Enterprise value $75.11B $51.74M -$113.94M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCLPRGOEPC
P/E 38.7x -1.3x -24.4x
P/FCF 20.9x 13.4x -125.6x
P/Operating cash flow 18.1x 9.4x –
P/S 3.7x 0.6x 0.6x
P/B 123.8x 0.9x 0.9x
P/Tangible book -95.2x 7.5x 1.9x
EV/EBITDA 22.5x -3.9x –
EV/EBIT 27.0x -3.2x –
EV/Revenue 4.0x 1.3x –
EV/FCF 22.5x 30.4x –
EV/Operating cash flow 19.6x 21.3x –
PEG (3Y EPS CAGR) 3.79 0.00 –

Growth

14 metrics
MetricCLPRGOEPC
Revenue growth (1Y) 5.9% -4.5% –
Revenue CAGR (3Y) 3.6% -4.2% –
Gross profit growth (1Y) 6.7% -12.9% –
Gross profit CAGR (3Y) 5.6% -6.8% –
Operating income growth (1Y) -26.1% -677.9% –
Operating income CAGR (3Y) 0.5% -116.4% –
Net income growth (1Y) -28.6% -3,316% –
Net income CAGR (3Y) 7.7% -655.7% –
EPS growth (1Y) -28.5% -3,304% –
EPS CAGR (3Y) 10.2% -651.2% –
Operating cash flow growth (1Y) 8.8% -36.0% –
Operating cash flow CAGR (3Y) 10.0% -14.3% –
Free cash flow growth (1Y) 10.0% -38.0% –
Free cash flow CAGR (3Y) 14.1% -16.8% –

Profitability

14 metrics
MetricCLPRGOEPC
Gross margin 60.6% 32.3% –
EBITDA margin 17.9% -31.8% –
Operating margin 14.8% -39.4% –
Pretax margin 13.9% -40.4% –
Net margin 9.6% -43.3% –
FCF margin 17.8% 4.1% –
Operating cash flow margin 20.5% 5.9% –
Return on equity 360.5% -71.4% –
Return on assets 13.0% -23.4% –
Return on invested capital 27.6% -27.9% –
Return on capital employed 31.2% -24.7% –
Asset turnover 1.3x 0.5x –
Cash conversion (OCF / net income) 2.0x -0.1x –
Stock comp / revenue 0.8% 1.1% –

Financial Health

11 metrics
MetricCLPRGOEPC
Debt / assets 46.1% 44.0% 36.2%
Debt / equity 12.1x 1.3x 0.9x
Net debt / EBITDA 1.6x -2.2x –
Debt / FCF 2.0x 19.6x –
Liabilities / assets 96.2% 67.4% 58.5%
Equity / assets 3.8% 32.6% 41.5%
Interest coverage 12.6x – –
Current ratio 1.0x 2.4x 1.8x
Quick ratio 0.5x 1.1x 0.8x
Cash ratio 0.2x 0.4x 0.6x
Altman Z-score 7.12 -0.43 –

Shareholder Returns

7 metrics
MetricCLPRGOEPC
Dividend yield 2.1% 7.1% 2.2%
Net buyback yield 1.4% – –
Shareholder yield 3.6% 7.1% 2.2%
Payout ratio (earnings) 84.2% – –
Payout ratio (FCF) 48.3% – –
Dividend growth (1Y) 0.9% – –
Dividend CAGR (3Y) 1.9% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCLPRGOEPC
Forward P/E 26.2xFY2026 6.7xFY2026 13.0xFY2027
EPS, next fiscal year $3.81FY2026 $2.44FY2026 $2.10FY2027
EPS growth, next FY +3.3%FY2026 -11.3%FY2026 +8.8%FY2027
EPS growth, the year after +10.5% -9.0% -1.9%
Revenue, next fiscal year $22.41BFY2026 $4.15BFY2026 $1.89BFY2027
Revenue growth, next FY +10.0%FY2026 -2.4%FY2026 -5.6%FY2027
Revenue growth, the year after +1.3% -3.5% +2.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCLPRGOEPC
Held by institutions 83.8% 100.0% 100.0%
Institutions holding 2,019 340 224
Change in shares held, QoQ 0.0% +6.4% +3.0%
Institutions buying 921 195 108
Institutions selling 722 92 79
Buyers to sellers 1.28 2.12 1.37

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CLPRGOEPC
CL 1.00 0.29 0.45
PRGO 0.29 1.00 0.38
EPC 0.45 0.38 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CL, PRGO and EPC?

Colgate Palmolive (CL) is the largest by market capitalisation: Colgate Palmolive (CL) $80.63B, Perrigo (PRGO) $2.31B, Edgewell Personal Care (EPC) $1.24B.

Which company is growing faster?

Colgate Palmolive (CL) grew revenue fastest over the trailing twelve months: Colgate Palmolive (CL) +5.9%, Perrigo (PRGO) -4.5%.

Which company is more profitable?

Colgate Palmolive (CL) has the highest net margin (Colgate Palmolive (CL) 9.6%, Perrigo (PRGO) -43.3%). On return on invested capital, Colgate Palmolive (CL) leads (Colgate Palmolive (CL) 27.6%, Perrigo (PRGO) -27.9%).

Which stock has performed better?

Over the past year Edgewell Personal Care (EPC) returned the most: Colgate Palmolive (CL) +26.5%, Perrigo (PRGO) +16.4%, Edgewell Personal Care (EPC) +48.2%. Over five years, Colgate Palmolive (CL) compounded fastest (Colgate Palmolive (CL) +5.0%/yr, Perrigo (PRGO) -17.8%/yr, Edgewell Personal Care (EPC) -8.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Colgate Palmolive (CL) 0.02%, Perrigo (PRGO) 0.00%, Edgewell Personal Care (EPC) 0.00%. Perrigo (PRGO) and Edgewell Personal Care (EPC) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Colgate Palmolive (CL) has been the steadiest (Colgate Palmolive (CL) 23.5%, Perrigo (PRGO) 49.6%, Edgewell Personal Care (EPC) 44.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CL, PRGO and EPC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Colgate Palmolive (CL) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.